904 related articles for article (PubMed ID: 27233840)
41. The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care.
Hollands GJ; Sutton S; Aveyard P
J Subst Abuse Treat; 2022 Jan; 132():108591. PubMed ID: 34391588
[TBL] [Abstract][Full Text] [Related]
42. Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.
Davies NM; Taylor AE; Taylor GM; Itani T; Jones T; Martin RM; Munafò MR; Windmeijer F; Thomas KH
Health Technol Assess; 2020 Feb; 24(9):1-46. PubMed ID: 32079557
[TBL] [Abstract][Full Text] [Related]
43. Extending varenicline preloading to 6 weeks facilitates smoking cessation: A single-site, randomised controlled trial.
Bohadana A; Freier-Dror Y; Peles V; Babai P; Izbicki G
EClinicalMedicine; 2020 Feb; 19():100228. PubMed ID: 32055787
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.
Rigotti NA; Pipe AL; Benowitz NL; Arteaga C; Garza D; Tonstad S
Circulation; 2010 Jan; 121(2):221-9. PubMed ID: 20048210
[TBL] [Abstract][Full Text] [Related]
45. Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand.
White JS; Dow WH; Rungruanghiranya S
Am J Prev Med; 2013 Nov; 45(5):533-42. PubMed ID: 24139765
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.
Hitsman B; Papandonatos GD; Gollan JK; Huffman MD; Niaura R; Mohr DC; Veluz-Wilkins AK; Lubitz SF; Hole A; Leone FT; Khan SS; Fox EN; Bauer AM; Wileyto EP; Bastian J; Schnoll RA
Addiction; 2023 Sep; 118(9):1710-1725. PubMed ID: 37069490
[TBL] [Abstract][Full Text] [Related]
47. The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance.
Cinciripini PM; Minnix JA; Robinson JD; Kypriotakis G; Cui Y; Blalock JA; Lam CY; Wetter DW
JMIR Form Res; 2023 Jun; 7():e39487. PubMed ID: 37338956
[TBL] [Abstract][Full Text] [Related]
48. Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
Ebbert J; Jimenez-Ruiz C; Dutro MP; Fisher M; Li J; Hays JT
Mayo Clin Proc; 2021 Jul; 96(7):1801-1811. PubMed ID: 34112520
[TBL] [Abstract][Full Text] [Related]
49. Comparative Safety of Smoking Cessation Pharmacotherapies During a Government-Sponsored Reimbursement Program.
Carney G; Maclure M; Malfair S; Bassett K; Wright JM; Dormuth CR
Nicotine Tob Res; 2021 Jan; 23(2):302-309. PubMed ID: 32484873
[TBL] [Abstract][Full Text] [Related]
50. Treatment of Tobacco Smoking: A Review.
Rigotti NA; Kruse GR; Livingstone-Banks J; Hartmann-Boyce J
JAMA; 2022 Feb; 327(6):566-577. PubMed ID: 35133411
[TBL] [Abstract][Full Text] [Related]
51. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
Rosen LJ; Galili T; Kott J; Goodman M; Freedman LS
Addiction; 2018 May; 113(5):805-816. PubMed ID: 29377409
[TBL] [Abstract][Full Text] [Related]
52. Varenicline Treatment for Waterpipe Smoking Cessation.
Chami HA; Zaouk N; Makki M; Tamim H; Shaya M; Talih F
Nicotine Tob Res; 2023 Jan; 25(1):111-119. PubMed ID: 35789389
[TBL] [Abstract][Full Text] [Related]
53. Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
Olawuyi O; Mathieson K
Curr Drug Saf; 2020; 15(3):173-180. PubMed ID: 32525783
[TBL] [Abstract][Full Text] [Related]
54. Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.
Stapleton J; West R; Hajek P; Wheeler J; Vangeli E; Abdi Z; O'Gara C; McRobbie H; Humphrey K; Ali R; Strang J; Sutherland G
Addiction; 2013 Dec; 108(12):2193-201. PubMed ID: 23859696
[TBL] [Abstract][Full Text] [Related]
55. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial.
Rigotti NA; Benowitz NL; Prochaska J; Leischow S; Nides M; Blumenstein B; Clarke A; Cain D; Jacobs C
JAMA; 2023 Jul; 330(2):152-160. PubMed ID: 37432430
[TBL] [Abstract][Full Text] [Related]
56. Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial.
Cox LS; Nollen NL; Mayo MS; Faseru B; Greiner A; Ellerbeck EF; Krebill R; Tyndale RF; Benowitz NL; Ahluwalia JS
JAMA; 2022 Jun; 327(22):2201-2209. PubMed ID: 35699705
[TBL] [Abstract][Full Text] [Related]
57. Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial.
Caponnetto P; Campagna D; Ahluwalia JS; Russell C; Maglia M; Riela PM; Longo CF; Busa B; Polosa R
BMC Med; 2023 Jul; 21(1):220. PubMed ID: 37403047
[TBL] [Abstract][Full Text] [Related]
58. Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo DM; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Addiction; 2022 Apr; 117(4):861-876. PubMed ID: 34636108
[TBL] [Abstract][Full Text] [Related]
59. QuitNic: A Pilot Randomized Controlled Trial Comparing Nicotine Vaping Products With Nicotine Replacement Therapy for Smoking Cessation Following Residential Detoxification.
Bonevski B; Manning V; Wynne O; Gartner C; Borland R; Baker AL; Segan CJ; Skelton E; Moore L; Bathish R; Chiu S; Guillaumier A; Lubman DI
Nicotine Tob Res; 2021 Feb; 23(3):462-470. PubMed ID: 32770246
[TBL] [Abstract][Full Text] [Related]
60. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K
Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
